ProQR Therapeutics PRQR
NASDAQ PRQR
$1.37 -0.01 (-0.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Total Current Liabilities (2013 - 2026)

Updated

ProQR Therapeutics' Total Current Liabilities was $40.54 million in the quarter ended Jun 30, 2026, up 8.2% from $37.45 million a year earlier but down 1.2% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Total Current Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Current Liabilities at ProQR Therapeutics came in at $36.65 million, down 13.0% from the prior year.

  • Total Current Liabilities shows a five-year compound annual growth rate of 25.5% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Total Current Liabilities was $42.11 million in the year ended Dec 31, 2024 (+13.8%), $37 million in the year ended Dec 31, 2023 (+67.3%), $22.12 million in the year ended Dec 31, 2022 (-32.3%) and $32.66 million in the year ended Dec 31, 2021 (+177.7%).
  • Quarterly Total Current Liabilities has moved between $18.42 million (the quarter ended Mar 31, 2023) and $43.53 million (the quarter ended Sep 30, 2024) over five years.
  • Compared with a year earlier, Total Current Liabilities was higher in four of the last eight quarters, with growth averaging 6.9%.
  • The best year-over-year quarter for Total Current Liabilities over five years was the quarter ended Sep 30, 2021 (growth of 223.8%); the worst was the quarter ended Sep 30, 2022 (a decline of 33.5%).
  • Per Business Quant data, PRQR's Total Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $41.04 million (quarter ended Mar 31, 2026), $37.76 million (quarter ended Dec 31, 2025) and $38.74 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 ProQR Therapeutics 145.89 Mn -314.77 Mn - 39.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.83 Mn
Mar 31, 2026 40.18 Mn
Dec 31, 2025 38.11 Mn
Sep 30, 2025 38.87 Mn
Jun 30, 2025 38.80 Mn
Mar 31, 2025 36.49 Mn
Dec 31, 2024 40.48 Mn
Sep 30, 2024 44.28 Mn
Jun 30, 2024 39.92 Mn
Mar 31, 2024 37.15 Mn
Dec 31, 2023 37.86 Mn
Sep 30, 2023 28.15 Mn
Jun 30, 2023 24.97 Mn
Mar 31, 2023 18.71 Mn
Dec 31, 2022 22.37 Mn
Sep 30, 2022 26.51 Mn
Jun 30, 2022 28.35 Mn
Mar 31, 2022 26.47 Mn
Dec 31, 2021 31.25 Mn
Sep 30, 2021 40.24 Mn
API Access

ProQR Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PRQR&period=max&api_key=YOUR_API_KEY